ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Iodine → tert-butyl(1-(5-((5R)-6-(benzyloxy)-7-oxo-1,6-diaza-bicyclo[3.2.1]octan-2-yl)-1,3,4-oxadiazol-2-yl)cyclopropyl)methylcarbamate

HRID 1427654
ノート
印刷プレビュー

反応式

HRID 1427654 の反応式
CCN(CC)CC.II.C1C=CC(P(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1.[C:29]([O:33][C:34](=[O:63])[NH:35][CH2:36][C:37]1([C:40]([NH:42][NH:43][C:44]([CH:46]2[CH2:52][CH2:51][C@@H:50]3[CH2:53][N:47]2[C:48](=[O:62])[N:49]3[O:54][CH2:55][C:56]2[CH:61]=[CH:60][CH:59]=[CH:58][CH:57]=2)=O)=[O:41])[CH2:39][CH2:38]1)([CH3:32])([CH3:31])[CH3:30]>C(Cl)Cl>[CH2:55]([O:54][N:49]1[C:48](=[O:62])[N:47]2[CH2:53][C@H:50]1[CH2:51][CH2:52][CH:46]2[C:44]1[O:41][C:40]([C:37]2([CH2:36][NH:35][C:34](=[O:63])[O:33][C:29]([CH3:32])([CH3:31])[CH3:30])[CH2:38][CH2:39]2)=[N:42][N:43]=1)[C:56]1[CH:61]=[CH:60][CH:59]=[CH:58][CH:57]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 807IodineHCID 8471TriethylamineHCID 11776TriphenylphosphineHCID 131732351tert-butyl(1-(2-((5R)-6-(benzyloxy)-7-oxo-1,6-diaza-bicyclo[3.2.1]octane-2-carbonyl)hydrazinecarbonyl)cyclopropyl)methylcarbamate

生成物 1

HCID 86701028tert-butyl(1-(5-((5R)-6-(benzyloxy)-7-oxo-1,6-diaza-bicyclo[3.2.1]octan-2-yl)-1,3,4-oxadiazol-2-yl)cyclopropyl)methylcarbamate
収率 83.1%

試薬・触媒・溶媒 1

HCID 6344Dichloromethane溶媒

実験手順

Et3N (8.3 g, 0.082 mol) was added to a 0° C. solution of I2 (10.43 g, 0.041 mol), PPh3 (10.76 g, 0.041 mol) in CH2Cl2 (250 mL). The mixture was allowed to warm to rt. After stirring at rt for 0.5 hr, tert-butyl(1-(2-((5R)-6-(benzyloxy)-7-oxo-1,6-diaza-bicyclo[3.2.1]octane-2-carbonyl)hydrazinecarbonyl)cyclopropyl)methylcarbamate (10 g, 0.0205 mol) was added. The mixture was stirred at rt for another 1 hr. The mixture was concentrated, EtOAc (250 mL) was added, and the mixture was filtered to remove Ph3PO. The filtrate was concentrated and the residue was purified by silica gel column chromatography (gradient elution 33˜50% EtOAc/petroleum ether) to afford tert-butyl (1-(5-((5R)-6-(benzyloxy)-7-oxo-1,6-diaza-bicyclo[3.2.1]octan-2-yl)-1,3,4-oxadiazol-2-yl)cyclopropyl)methylcarbamate (8 g, 83%) as a white solid. ESI-MS (EI+, m/z): 470.3 [M+H]+.

後処理

  1. stirringThe mixture was stirred at rt for another 1 hr
  2. concentrationThe mixture was concentrated
  3. additionEtOAc (250 mL) was added
  4. filtrationthe mixture was filtered
  5. customto remove Ph3PO
  6. concentrationThe filtrate was concentrated
  7. customthe residue was purified by silica gel column chromatography (gradient elution 33˜50% EtOAc/petroleum ether)

出典と根拠

ORDレコード
ord-e16da0dcd0594a849809ee6cafffd0fb
出典データセット
uspto-grants-2015_01
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08933233B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート